SLC2A1 and neoplasm: Our study demonstrates that elevated Ras/Erk plus Wnt/ß-catenin signalling upregulates Pi3K/Akt/Glut1 activity: the result is increased glucose uptake, enhanced glucuronidation, and emergent drug resistance in byn>RasG12V tumours (Fig. 6d).